Senores Pharmaceuticals
SENORES · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 30, 2024

Stock Price vs Company Growth
1d
6.0%
1w
5.6%
1m
4.5%
3m
47.3%
6m
68.2%
1y
106.3%
all
73.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,326 6.0%
880
1,509
Company Overview

Sales
692 Cr
Growth: 42.6%
Profit after Tax
126 Cr
Growth: 9.5%
Small Cap
6,108 Cr
P/E: 46.7x
Industry P/E: 32.3x
Fundamentals

Sales (Cr) ₹ 692
Growth 42.6%
EBITDA 29.6%
P/S 8.8x
Dividend 0.0%
P/E 46.7x
Book Value ₹ 209
PEG Ratio 1.1x
ROE 14.0%
P/B 6.3x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Senores Pharmaceuticals Limited was originally incorporated as ‘Senores Pharmaceuticals Private Limited’ under the Companies Act, 2013 through certificate of incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
Investors (13)
Followers (1)